Although chemotherapy is free, some families refused to start treatment or discounted therapy early during the disease 61 (43%). This reluctance is due to many financial restrains and social beliefs. Although a large number of patients refused treatment, there a significant improvement when compared to the previous study1. As expected, the survival rate in these two groups is reduced. Our results are comparable to some low-income countries16,17,18.